000 03084nam a22003735i 4500
001 309660
003 MX-SnUAN
005 20160429160316.0
007 cr nn 008mamaa
008 150903s2008 sz | o |||| 0|eng d
020 _a9783764377243
_99783764377243
024 7 _a10.1007/9783764377243
_2doi
035 _avtls000362821
039 9 _a201509031020
_bVLOAD
_c201405070334
_dVLOAD
_y201402211058
_zstaff
040 _aMX-SnUAN
_bspa
_cMX-SnUAN
_erda
050 4 _aRM1-950
100 1 _aWeinberg, Jeffrey M.
_eeditor.
_9350061
245 1 0 _aTreatment of Psoriasis /
_cedited by Jeffrey M. Weinberg.
264 1 _aBasel :
_bBirkhäuser Basel,
_c2008.
300 _brecurso en línea.
336 _atexto
_btxt
_2rdacontent
337 _acomputadora
_bc
_2rdamedia
338 _arecurso en línea
_bcr
_2rdacarrier
347 _aarchivo de texto
_bPDF
_2rda
490 0 _aMilestones in Drug Therapy
500 _aSpringer eBooks
505 0 _aIntroduction: History of psoriasis and psoriasis therapy -- The pathophysiology of psoriasis -- Psoriasis and psoriatic arthritis: a clinical review -- Topical therapy I: corticosteroids and vitamin D analogs -- Topical therapy II: retinoids, immunomodulators, and others -- Ultraviolet and laser therapy -- Traditional systemic therapy I: methotrexate and cyclosporine -- Traditional systemic therapy II: retinoids and others (hydroxyurea, thiopurine antimetabolites, mycophenlic acid, sulfasalazine) -- Biologic therapy for psoriasis: an overview of infliximab, etanercept, adalimumab, efalizumab, and alefacept -- Biologic and oral therapies in development for the treatment of psoriasis -- Quality of life issues in psoriasis.
520 _aPsoriasis is an inherited skin disease that has been diagnosed in 4.5 million adults in the United States. About 10 percent to 30 percent of people with psoriasis also develop psoriatic arthritis, which causes pain, stiffness and swelling in and around the joints. The book reviews the clinical manifestations of these two entities. The main focus is on the evolving paradigm of therapy. Topical and ultraviolet therapy are discussed first, followed by traditional systemic therapy. A major focus is on biologic therapies. New agents in development are also reviewed. The book concludes with an evaluation of the quality of life impact of this disease. This volume provides an in-depth overview of the current state of psoriasis and its management. It is of interest to clinicians, researchers, and even patients who wish to learn more. It is also of interest to those in the pharmaceutical industry, and those in finance who cover the pharmaceutical field.
590 _aPara consulta fuera de la UANL se requiere clave de acceso remoto.
710 2 _aSpringerLink (Servicio en línea)
_9299170
776 0 8 _iEdición impresa:
_z9783764377229
856 4 0 _uhttp://remoto.dgb.uanl.mx/login?url=http://dx.doi.org/10.1007/978-3-7643-7724-3
_zConectar a Springer E-Books (Para consulta externa se requiere previa autentificación en Biblioteca Digital UANL)
942 _c14
999 _c309660
_d309660